Therapy News and Research

RSS

BHD launches Statin Induced Myopathy Genotype test

Boston Heart Diagnostics (BHD) announced today the commercial launch of the Statin Induced Myopathy (SLCO1B1) Genotype test licensed from the University of Oxford's technology commercialization company Isis Innovation.

31 May 2012

GE to provide attendees with overview of new oncology solutions at ASCO annual meeting

GE Healthcare, is working to help physicians potentially improve patient care throughout the breast cancer journey through one of the most comprehensive portfolios of technologies in the industry available today.

31 May 2012

Pfizer’s XALKORI now available in Canada

Pfizer Canada is pleased to announce that XALKORI (crizotinib) is now available in Canada. Recently approved with conditions by Health Canada, XALKORI is an oral monotherapy for patients with anaplastic lymphoma kinase (ALK)-positive advanced or metastatic non-small cell lung cancer (NSCLC).

31 May 2012

Study shows how tafamidis drug works against amyloid disease

Scientists from The Scripps Research Institute and Pfizer Inc. have published a new study showing how a new drug called tafamidis (Vyndaqel) works.

31 May 2012

Experimental drug shows promise for elderly chronic leukemia patients

The experimental drug ibrutinib is highly active and well tolerated in elderly, treatment-naive patients with chronic lymphocytic leukemia, US researchers report.

30 May 2012

Insulin use linked to lung cancer risk in diabetes

Postmenopausal women with treated diabetes may be at an increased risk for lung cancer, particularly if they are on insulin, say researchers.

30 May 2012

Revised QFracture tool shows enhanced risk-prediction

Researchers have developed a new algorithm that may improve upon existing methods for identifying patients at high risk for fracture in primary care.

30 May 2012

Law aims to illuminate financial links between doctors and pharmaceutical companies

A Colorado School of Public Health researcher has found that laws designed to illuminate financial links between doctors and pharmaceutical companies have little or no effect on what drugs physicians prescribe.

30 May 2012

DMARD not superior to oral therapy in long-term treatment of patients with JIA

A retrospective analysis of methotrexate (MTX) safety data found that injection of this disease-modifying anti-rheumatic drug (DMARD) was not superior to oral therapy in long-term treatment of patients with juvenile idiopathic arthritis (JIA). Findings published in Arthritis Care & Research, a peer-reviewed journal of the American College of Rheumatology (ACR), suggest that with similar efficacy and tolerability the more comfortable oral approach may be more suitable to treat pediatric arthritis patients.

30 May 2012

Study reveals new evidence of trans-cranial bright light's effect to brain functions

A recent placebo-controlled study reveals new evidence of trans-cranial bright light's effect to brain functions when administered through the ear. Bright light stimulation was found to increase activity in brain areas related to processing of visual sensory information and tactile stimuli. The findings constitute the first ever published scientific article about functional modulation of the brain with bright light delivered to the brain through the ears. The study was published today May 29th, 2012 in the World Journal of Neuroscience.

30 May 2012

EWMA: International consensus on appropriate usage of silver dressings in wound care launched

An international consensus on the appropriate usage of silver dressings in wound care was launched this month at the European Wound Management Association (EWMA)'s Conference in Vienna. The guidelines brought together 12 expert clinicians from 10 different countries to respond to recent evidence reviews that have questioned the widespread use of silver in advanced wound care.

30 May 2012

JTCC to present latest findings in blood-cancer research at ASCO annual meeting

Physicians and researchers at John Theurer Cancer Center at HackensackUMC, one of the nation's top 50 cancer centers, will present the latest findings in blood-cancer research at the 2012 American Society of Clinical Oncology (ASCO) annual meeting in Chicago on June 1-5. Their involvement in these studies is part of John Theurer Cancer Center's continued focus to bolster its research program.

30 May 2012

Intensity of itching in eczema linked to depression

Itch intensity in atopic dermatitis is related to the stress level and emotional wellbeing of patients, say researchers.

30 May 2012

FRAX tool ‘resistant’ to osteoporosis treatment effects

Osteoporosis therapy does not invalidate the use of the World Health Organization’s fracture risk assessment system for fracture prediction, study findings indicate.

30 May 2012

Exelixis files NDA with FDA for cabozantinib to treat MTC

Exelixis, Inc. today announced that it has completed the filing of its rolling New Drug Application (NDA) with the U.S. Food and Drug Administration (FDA) for cabozantinib as a treatment for patients with progressive, unresectable, locally advanced, or metastatic medullary thyroid cancer.

30 May 2012

New treatment for sickle cell disease developed by Emmaus Medical receives positive opinion from EMA

Emmaus Medical, Inc., a pharmaceutical company developing a new treatment for sickle cell disease, and subsidiary of Emmaus Life Sciences, Inc., announced today that its investigational L-glutamine treatment for sickle cell disease has received a positive opinion recommending orphan medicinal product designation by the European Medicines Agency’s (EMA) Committee for Orphan Medicinal Products (COMP). The designation allows Emmaus ten years of marketing exclusivity in EU member countries after the product obtains marketing authorization, as well as streamlined regulatory review processes and registration and other fee reductions.

30 May 2012

Studies outline dilemmas on new generic heart drugs, hormone replacement therapy

One heart drug's move to generic status has complicated treatment options for some patients and doctors, the Wall Street Journal reports. Also, another study raises concerns about hormone replacement therapy in women.

30 May 2012

State roundup: The effects of proposed Calif. budget cuts; Fewer free vaccinations in Texas

Low-income children in rural California communities are in jeopardy of losing their doctors and health care plans under Gov. Jerry Brown's budget proposal, state lawmakers, doctors and health advocates say. The governor is proposing to transfer nearly 900,000 children enrolled in Healthy Families, the state's Children's Health Insurance Program, to Medi-Cal – a program aimed at serving the state's poorest families, seniors and disabled residents.

30 May 2012

CHOC Children's research project receives $5.5M CIRM grant

A CHOC Children's research project, under the direction of Philip H. Schwartz, Ph.D., senior scientist at the CHOC Children's Research Institute and managing director of the facility's National Human Neural Stem Cell Resource, has been awarded a $5.5 million grant from the California Institute for Regenerative Medicine.

30 May 2012

Link between women's health issues and gum disease

Women, keep those toothbrushes and dental floss handy. A comprehensive review of women's health studies by Charlene Krejci, associate clinical professor at the Case Western Reserve University School of Dental Medicine, has shown a link between women's health issues and gum disease.

30 May 2012

Therapy News and Research

BHD launches Statin Induced Myopathy Genotype test

GE to provide attendees with overview of new oncology solutions at ASCO annual meeting

Pfizer’s XALKORI now available in Canada

Study shows how tafamidis drug works against amyloid disease

Experimental drug shows promise for elderly chronic leukemia patients

Insulin use linked to lung cancer risk in diabetes

Revised QFracture tool shows enhanced risk-prediction

Law aims to illuminate financial links between doctors and pharmaceutical companies

DMARD not superior to oral therapy in long-term treatment of patients with JIA

Study reveals new evidence of trans-cranial bright light's effect to brain functions

EWMA: International consensus on appropriate usage of silver dressings in wound care launched

JTCC to present latest findings in blood-cancer research at ASCO annual meeting

Intensity of itching in eczema linked to depression

FRAX tool ‘resistant’ to osteoporosis treatment effects

Exelixis files NDA with FDA for cabozantinib to treat MTC

New treatment for sickle cell disease developed by Emmaus Medical receives positive opinion from EMA

Studies outline dilemmas on new generic heart drugs, hormone replacement therapy

State roundup: The effects of proposed Calif. budget cuts; Fewer free vaccinations in Texas

CHOC Children's research project receives $5.5M CIRM grant

Link between women's health issues and gum disease

The Critical Role of Sample Storage in Drug Discovery and Development

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

Latest News